Moody's Investors Service has upgraded the long-term and underlying ratings on San Diego-based Sharp HealthCare's revenue bonds to "Aa3" from "A1."
The rating upgrade was supported by a number of factors, including the system's strong operating performance and growth in market share.
Sharp also faces some challenges, which were considered for the rating upgrade, such as ongoing changes to the payer and provider markets.
More articles on healthcare finance:
El Paso Children's Hospital considering bankruptcy
5 pieces of advice health system CFOs shared this month
IRS provides guidance on 'Cadillac' health plan tax